Evidence map›Paper›PMID 26668315›Full record

ArticleThe Journal of biological chemistry2016

Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.

Nadejda L Korneeva, Anren Song, Hermann Gram, Mary Ann Edens, Robert E Rhoads

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Adaptive responses toProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  12. Review
  13. Article
  14. Translating Translation to Mechanisms of Cardiac Hypertrophy.Journal of cardiovascular development and disease · 2020
    Review
  15. Infection by the Protozoan ParasiteFrontiers in cellular and infection microbiology · 2020
    Article
  16. Article
  17. Targeting Translation of mRNA as a Therapeutic Strategy in Cancer.Current hematologic malignancy reports · 2019
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Nadejda L KorneevaFrom the Departments of Emergency Medicine and Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130-3932, and nkorne@lsuhsc.edu.
Anren SongBiochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130-3932, and.
Hermann Gramthe Novartis Institute for Biomedical Research, Forum 1, CH-4002 Basel, Switzerland.
Mary Ann EdensFrom the Departments of Emergency Medicine and.
Robert E RhoadsBiochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130-3932, and.
Louisiana State University Health Sciences Center Shreveport · USNovartis (Switzerland) · CH

Funding

REGULATION OF OVALBUMIN SYNTHESIS IN CHICK OVIDUCTR01GM020818 · NIGMS · UNIVERSITY OF KENTUCKY · PI RHOADS, ROBERT E. · 1985 to 2009
$3.5M
NIGMS NIH HHS 2R01GM20818NIGMS NIH HHS R01 GM020818
6 · The paper itself

Abstract

The MAPK-interacting kinases 1 and 2 (MNK1 and MNK2) are activated by extracellular signal-regulated kinases 1 and 2 (ERK1/2) or p38 in response to cellular stress and extracellular stimuli that include growth factors, cytokines, and hormones. Modulation of MNK activity affects translation of mRNAs involved in the cell cycle, cancer progression, and cell survival. However, the mechanism by which MNK selectively affects translation of these mRNAs is not understood. MNK binds eukaryotic translation initiation factor 4G (eIF4G) and phosphorylates the cap-binding protein eIF4E. Using a cell-free translation system from rabbit reticulocytes programmed with mRNAs containing different 5'-ends, we show that an MNK inhibitor, CGP57380, affects translation of only those mRNAs that contain both a cap and a hairpin in the 5'-UTR. Similarly, a C-terminal fragment of human eIF4G-1, eIF4G(1357-1600), which prevents binding of MNK to intact eIF4G, reduces eIF4E phosphorylation and inhibits translation of only capped and hairpin-containing mRNAs. Analysis of proteins bound to m(7)GTP-Sepharose reveals that both CGP and eIF4G(1357-1600) decrease binding of eIF4E to eIF4G. These data suggest that MNK stimulates translation only of mRNAs containing both a cap and 5'-terminal RNA duplex via eIF4E phosphorylation, thereby enhancing the coupled cap-binding and RNA-unwinding activities of eIF4F.

Indexed as

Amino Acid SubstitutionAnimalsCell-Free SystemEukaryotic Initiation Factor-4EEukaryotic Initiation Factor-4GHumansIntracellular Signaling Peptides and ProteinsInverted Repeat SequencesMutant ProteinsPeptide FragmentsPhosphorylationProtein BiosynthesisProtein Interaction Domains and MotifsProtein Kinase InhibitorsProtein Processing, Post-TranslationalProtein Serine-Threonine KinasesEIF4G1 protein, humanEukaryotic Initiation Factor-4EEukaryotic Initiation Factor-4GIntracellular Signaling Peptides and ProteinsMKNK1 protein, humanMKNK2 protein, humanMutant ProteinsPeptide FragmentsProtein Kinase InhibitorsProtein Serine-Threonine KinasesRecombinant ProteinsRNARNA CapsRNA, MessengerRNA, recombinanteukaryotic translation initiationeukaryotic translation initiation factor 4E (eIF4E)eukaryotic translation initiation factor 4G (eIF4G)mRNAphosphorylation

Identifiers

PMID26668315
PMCPMC4751387
OpenAlexW2254118178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.